Patent Assignment
Reel/Frame 064889/0459
Corrective Assignment to Correct the Assignee Name from Tisento Therapeutics, Inc. to Tisento Therapeutics Inc. Previously Recorded on Reel 064792 Frame 0500. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-09-13
Pages: 15
Assignor
CYCLERION THERAPEUTICS, INC.
Executed: 2023-07-28
Assignee
TISENTO THERAPEUTICS INC.
245 FIRST STREET, RIVERVIEW II, 18TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(45)
Sgc Stimulators
PCT:
PCT/US2017/049834 ↗
Treatment of Cns Diseases with Sgc Stimulators
PCT:
PCT/US2017/060299 ↗
Process for Preparing Soluble Guanylate Cyclase Stimulators
PCT:
PCT/US2019/021076 ↗
Crystalline Forms of an Sgc Stimulator
PCT:
PCT/US2019/021080 ↗
Use of Sgc Stimulators for the Treatment of Mitochonrial Disorders
PCT:
PCT/US2019/041437 ↗
Deuterated Sgc Stimulators
PCT:
PCT/US2021/024189 ↗
Treatment of Cognitive Impairment with a Cns-Penetrant Sgc Stimulator
PCT:
PCT/US2021/054632 ↗
Treatment of Cns Diseases with Sgc Stimulators
PCT:
PCT/US2022/025308 ↗
Sgc Stimulators
PCT:
PCT/US2022/025310 ↗
Treatment of Mitochondrial Diseases with a Cns-Penetrant Sgc Stimulator
PCT:
PCT/US2023/024932 ↗
Treatment of Cognitive Impairment Associated with Schizophrenia (Cias) with a Cns-Penetrant Sgc Stimulator in Combination with Antipsychotics
PCT:
PCT/US2023/028709 ↗
sGC STIMULATORS
Sgc Stimulators
TREATMENT OF CNS DISEASES WITH sGC STIMULATORS
Process for Preparing Soluble Guanylate Cyclase Stimulators
CRYSTALLINE FORMS OF 8-(2-FLUOROBENZYL)-6-(3-(TRIFLUOROMETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO[1,2-a]PYRAZINE AS sGC STIMULATORS
sGC STIMULATORS
Application:
17/112,351 →
Publication:
US 2021/0087198
USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS
sGC STIMULATORS
DEUTERATED sGC STIMULATORS
Application:
17/913,273 →
Publication:
US 2023/0130739
CRYSTALLINE FORMS OF 8-(2-FLUOROBENZYL)-6-(3-(TRIFLUOROMETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO[1,2-a]PYRAZINE AS sGC STIMULATORS
Substituted Amidrazones as Intermediates in the Process for Preparing Soluble Guanylate Cyclase Stimulators
TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR
Application:
18/031,371 →
Publication:
US 2023/0372335
TREATMENT OF CNS DISEASES WITH sGC STIMULATORS
Application:
18/196,826 →
Publication:
US 2023/0381153
sGC STIMULATORS
Application:
62/382,942 →
TREATMENT OF CNS DISEASES WITH sGC STIMULATORS
Application:
62/419,059 →
sGC STIMULATORS
Application:
62/423,445 →
sGC STIMULATORS
Application:
62/468,598 →
sGC STIMULATORS
Application:
62/482,486 →
Process for Preparing Soluble Guanylate Cyclase Stimulators
Application:
62/639,642 →
CRYSTALLINE FORMS OF AN sGC STIMULATOR
Application:
62/639,846 →
Use of Sgc Stimulators for the Treatment of Mitochonrial Disorders
Application:
62/696,582 →
USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS
Application:
62/697,671 →
DEUTERATED sGC STIMULATORS
Application:
63/000,040 →
TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR
Application:
63/090,849 →
Treatment of Cognitive Impairment with a Cns-Penetrant Sgc Stimulator
Application:
63/135,797 →
sGC STIMULATORS
Application:
63/177,020 →
TREATMENT OF CNS DISEASES WITH sGC STIMULATORS
Application:
63/177,023 →
sGC STIMULATORS
Application:
63/229,248 →
TREATMENT OF CNS DISEASES WITH sGC STIMULATORS
Application:
63/229,251 →
TREATMENT OF MITOCHONDRIAL DISEASES WITH A CNS-PENETRANT sGC STIMULATOR
Application:
63/350,708 →
TREATMENT OF COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA (CIAS) WITH A CNS-PENETRANT sGC STIMULATOR IN COMBINATION WITH ANTIPSYCHOTICS
Application:
63/392,643 →
TREATMENT OF MITOCHONDRIAL DISEASES WITH A CNS-PENETRANT sGC STIMULATOR
Application:
63/410,829 →
Treatment of Mitochondrial Diseases with Sgc Stimulators
Application:
63/417,120 →
sGC STIMULATORS
Application:
63/417,180 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2018
From: RENNIE, GLEN ROBERT; IYENGAR, RAJESH R.; LEE, THOMAS WAI-HO; NAKAI, TAKASHI
To: IRONWOOD PHARMACEUTICALS, INC.
Reel/Frame 045766/0135 →
Assignment of Assignor's Interest
Apr 10, 2019
From: IRONWOOD PHARMACEUTICALS, INC.
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 048853/0001 →
Assignment of Assignor's Interest
Apr 23, 2019
From: RENNIE, GLEN ROBERT; IYENGAR, RAJESH R.; LEE, THOMAS WAI-HO; NAKAI, TAKASHI
To: IRONWOOD PHARMACEUTICALS, INC.
Reel/Frame 048969/0569 →
Assignment of Assignor's Interest
Oct 3, 2019
From: HADCOCK, JOHN R.
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 050609/0426 →
Assignment of Assignor's Interest
Nov 18, 2019
From: JUNG, JOON; LEE, THOMAS WAI-HO; IYENGAR, RAJESH R.; PERL, NICHOLAS ROBERT
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 051036/0795 →
Assignment of Assignor's Interest
Oct 28, 2020
From: STORZ, THOMAS
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 054199/0222 →
Assignment of Assignor's Interest
Dec 15, 2020
From: NTI-ADDAE, KWAME W.; PRASAD, LEENA KUMARI; STORZ, THOMAS
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 054656/0239 →
Assignment of Assignor's Interest
Feb 9, 2021
From: HADCOCK, JOHN R.
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 055198/0620 →
Assignment of Assignor's Interest
Mar 18, 2021
From: RENNIE, GLEN ROBERT; IYENGAR, RAJESH R.; LEE, THOMAS WAI-HO; RENHOWE, PAUL ALLAN
To: IRONWOOD PHARMACEUTICALS, INC
Reel/Frame 055644/0178 →
Assignment of Assignor's Interest
Mar 18, 2021
From: IRONWOOD PHARMACEUTICALS, INC.
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 055644/0220 →
Assignment of Assignor's Interest
Apr 11, 2023
From: RENNIE, GLEN ROBERT; IYENGAR, RAJESH R.; LEE, THOMAS WAI-HO; RENHOWE, PAUL ALLAN
To: IRONWOOD PHARMACEUTICALS, INC.
Reel/Frame 063288/0321 →
Assignment of Assignor's Interest
Apr 13, 2023
From: IRONWOOD PHARMACEUTICALS, INC.
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 063316/0835 →
Assignment of Assignor's Interest
Sep 1, 2023
From: CYCLERION THERAPEUTICS, INC.
To: TISENTO THERAPEUTICS, INC.
Reel/Frame 064792/0500 →